White House Rx-Price Report Criticizes 340B As Azar Suggests Changes

February 09, 2018
Nonprofit hospitals say a new report on drug pricing that is critical of the 340B program, along with a reported proposal from HHS Secretary Alex Azar to tie 340B reimbursement to charity care, shows the administration doesn't understand the 340B drug discount program, while other lobbyists say the report may be setting up both the president's upcoming budget request and 340B reform bills on Capitol Hill. The White House Council of Economic Advisors released a drug-price report Friday (Feb. 9)...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.